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Abstract
Natural killer (NK)-cell enteropathy (NKCE) and lymphomatoid gastropathy (LG) are closely related lymphoproliferative
disorders (LPDs) composed of mature and Epstein–Barr virus (EBV)-negative NK-cells. Although these uncommon and indo-
lent lymphoid proliferations mostly arise within the gastrointestinal (GI) tract as their designations implies, a few cases have been
reported outside the GI tract. We hereby describe a unique case of lymph node infiltration by such EBV-negative NK-cell
proliferation fortuitously found during routine examination of a gallbladder resected for biliary lithiasis. The histologic, pheno-
typic, and molecular features of this NK-cell proliferation, which were very similar if not identical to those previously reported in
NKCE or LG, suggest that similar indolent EBV-negative NK-cell LPDs may also occasionally involve lymph nodes.
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Introduction
Several cases of a particular Epstein–Barr virus (EBV)-
negative natural killer (NK)-cell proliferation occurring
mainly in the gastrointestinal (GI) tract and following an
indolent course have been recently reported [1–16]. The
clinico-pathologic spectrum of this rare lymphoprolifera-
tive disorder (LPD), initially described as lymphomatoid
gastropathy and more commonly referred to as NK-cell
enteropathy (NKCE) [1–16], remains not fully character-
ized. Herein, we describe an EBV-negative NK-cell pro-
liferation that was fortuitously found in the cystic duct
lymph node of a cholecystectomy.
Case report
A37-year-old Caucasianmale with no previousmedical his-
tory underwent laparoscopic cholecystectomy for symptom-
atic biliary lithiasis. The gallbladder contained gallstones,
had a moderately thickened wall, and no obvious mucosal
lesion. A 1.3-cm lymph nodewas adjacent to the cystic duct,
which was free of stone. Histologically, the gallbladder
showed hyperplastic and inflammatory changes consistent
with xanthogranulomatous cholecystitis, and the cystic duct
was normal. Beside benign reactive changes with B cell fol-
licular hyperplasia, the lymph node was partially obliterated
by a relatively circumscribed and vaguely nodular infiltrate
of monotonous medium-sized cells with moderately abun-
dant pale cytoplasm (Fig. 1a–b). No cytoplasmic granules
were visible. Nuclei were round to oval with slightly irregu-
lar contours, somewhat open chromatin and inconspicuous
nucleoli (Fig. 1c). There were rare apoptotic bodies, fewmi-
toses, and scattered histiocytes. By immunohistochemistry,
the pale cells were positive for CD2, cytoplasmic CD3 (± ),
CD7, CD56, perforin, granzyme B (± ) and T-cell intracellu-
lar antigen (TIA)-1, and negative for T-cell receptor β
(TCRβ), TCRδ, CD1a, CD4, CD5, CD8, CD10, CD20,
CD23, CD30, CD34, CD57, CD79a, CD123, CXCL13,
ICOS, PD1, S100, and myeloperoxydase (Fig. 2). The Ki-
67 proliferation index was approximately 10%. EBV-
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encoded RNA (EBER) in situ hybridization (ISH) was neg-
ative. Polymerase chain reaction–based clonality analysis
did not demonstrate clonal rearrangement of the TR genes
(TRB and TRG). Next-generation sequencing (NGS) analy-
sis using a panel of 26 genes designed for peripheral T-cell
lymphomas (ARID1A, ATM, BCOR, CARD11, CCR4,
CD28, CTNNB1, DDX3X, DNMT3A, FYN, IDH2, IRF4,
JAK1, JAK3, KMT2D, PIK3CD, PLCG1, PRKCB, RHOA,
SETD2, STAT3, STAT5B, TET2, TNFRSF1B, TP53, VAV1)
disclosed a mutation involving the exon 4 of the DNMT3A
gene (c.178-9C>T) with a variant allele fraction (VAF) of
46%, also described in the general population at a very low
frequency and interpreted as a constitutional variant. FISH
analysis using a JAK2 break apart probe (9p24) showed a
normal hybridization pattern.
Based on these findings, an “enteropathy-like” NK-cell
lymphoproliferation was considered. An extensive clinical
work-up, including peripheral blood analysis, computed to-
mography (CT) scan, positron emission tomography (PET)
scan, esophagogastroduodenoscopy, and colonoscopy, did
not demonstrate any abnormal finding.Multiple biopsies from
the stomach, duodenum, ileum, and colon showed essentially
normal histology. PET scan disclosed a small thyroid nodule,
benign by fine needle aspiration cytology. No further therapy
was given. The patient is still asymptomatic 18 months later.
Discussion
Except for the unusual location within a lymph node, the
features of this EBV-negative NK-cell proliferation are very
similar to those described in NKCE, of which forty-seven
cases have been reported [1–16]. The clinical features of these
uncommon lymphoid proliferations, which share some fea-
tures with indolent T-cell LPDs of the GI tract [17, 18], are
summarized in Table 1. There were 19 men and 28 women
ranging in age from 9 to 76 years, only four patients were
younger than 30 years, and the median age was 57.5 years
[1–16]. With the exception of three cases [11, 14, 16], all
patients were diagnosed with GI involvement [1–16].
Twenty-eight cases occurred in the stomach, duodenum, or
in several upper GI sites; seven cases involved the lower GI
tract; and in nine cases there was concomitant involvement of
the upper and lower GI mucosa [1–16]. In roughly half of the
cases (21/44) the patients had no specific complaints and the
lesions were fortuitously discovered by endoscopy performed
for check-up or screening [1–16]. Conversely, in 23/44 cases
various symptoms were recorded, mostly vague or non-
specific abdominal or epigastric pain or discomfort, some-
times diarrhea or weight loss, for which clinical workup and
endoscopic investigations eventually led to the diagnosis
[1–16]. At endoscopy, the altered mucosa often consists of
Fig. 1 Histopathology of the lymph node. a Panoramic view showing
partial replacement of the lymphoid tissue by relatively circumscribed
nodules (lower right). Elsewhere, the nodal architecture is preserved
with follicular hyperplasia. b The nodules are composed of monotonous
and medium-sized lymphoid cells. c Cytological features at high power.
Hematoxylin and eosin stain; original magnifications × 8, × 50, and ×
400, respectively
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erythematous, flat or polypoid lesions, superficial erosions, or
ulcers [1–16]. The clinical course is particularly indolent, with
spontaneous resolution or persistence despite various kinds of
therapies, for up to several years in some patients [1–16].
Unlike indolent T-cell LPDs of the GI tract, progression to a
more aggressive disease or nodal involvement has not yet
been documented, although imaging studies showed enlarged
regional lymph nodes in some patients [4, 9]. The cases re-
ported outside the GI tract were incidental microscopic dis-
coveries during gallbladder examination in two patients (33-
and 65-year-old) who underwent cholecystectomy for chronic
cholecystitis or biliary colic, and a symptomatic vaginal mass
in a 34-year-old woman [11, 14, 16]. The case reported here is
the first example of nodal involvement by an indolent EBV-
negative NK-cell LPD similar to NKCE or LG. Interestingly,
the involved lymph node was adjacent to the gallbladder, sug-
gesting that outside of the GI tract, the biliary region may be a
site of predilection for this disorder, which may possibly orig-
inate from a peculiar tissue-specific NK-cell subset, as has
been proposed in some studies [3, 5, 9, 13].
NKCE is usually composed of medium to large-sized lym-
phoid cells that contain variable amounts of pale cytoplasm,
nuclei with slightly irregular contours, open chromatin, and in-
conspicuous nucleoli [1–16]. Inmost cases, atypical cells diffuse-
ly infiltrate the lamina propria of the mucosa [1–16].
Occasionally, there may be some spilling into the glandular ep-
ithelium. Extension into the submucosa was reported in some
cases [1–16]. Importantly, there is no marked cellular atypia,
no significant mitotic activity, and no angiocentricity,
angiodestructive growth or necrosis [1–16]. Immunophenotypic
features of the reported cases show a very homogeneous profile
consistent withmatureNK cell, including expression of cytoplas-
mic CD3, CD7, CD56, and cytotoxic granules-associated mole-
cules in virtually all cases [1–16]. CD2 expression is detected in a
subset of the cases (68%), a few CD8+ cases have been reported
(4/43, 9%) [9, 10, 12], while CD4, CD5, and TCR isoforms (β or
γ chains) are consistently negative. Ki-67 proliferation index is
typically reported as low or quantified lower than 50%, but in 5/
26 cases (19%) a higher fraction of cycling cells was reported, up
to 90%. EBER ISH was negative in all cases, and no clonal
rearrangement of the TR genes was found in any of the cases
where clonality was investigated [1–16].
Some studies have suggested that an abnormal immune
response, possibly related to yet unknown antigen(s), could
underline NKCE pathogenesis [3, 5, 9, 13, 16]. In one patient
with high titers of antigliadin antibodies, the lesions regressed
significantly under gluten-free and lactose-free diet [1].
Several gastric cases had concomitant Helicobacter pylori in-
fection [2, 6–8, 10, 12]. However, overall, no firm relationship
with a specific factor or condition could be demonstrated
Fig. 2 Immunophenotypic characteristics of the lymphoproliferation.
The cells are positive for CD2 (a), cytoplasmic CD3 (b), CD7 (d),
CD56 (i), perforin (g), and TIA1 (h). They are negative for CD5 (c),
CD4 (e), CD8 (f), and CD57 (j). CD4 and CD8 stain a few reactive T

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































[1–16]. In a recent study using a large hematology-oriented
NGS panel, a somatic JAK3 mutation consisting of a small in
frame deletion in exon 12 was identified in 3/10 patients with
NKCE [15]. Other non-recurrent mutations involving PTPRS,
AURKB, AXL, ERBB4, IGF1R, PIK3CB, CUL3, CHEK2,
RUNX1T1, CIC, SMARCB1, and SETD5 were found in seven
cases [15]. In a few cases subject to extensive genetic testing
including 3/10 NKCE and the vaginal mass recently reported
[15, 16], however, no mutation was identified. In our patient,
NGS analysis of 26-genes T-cell lymphoma panel found no
pathogenic mutation and in particular no JAK3 deletion, but
one cannot exclude genetic aberration(s) in other genes not tested
in this panel. Thus, indolent NK-cell LPDs may represent a
spectrum ranging from polyclonal to clonal, the latter related to
mutations promoting the clonal expansion of NK cells, notably
those deregulating the JAK/STAT pathway which represent on-
cogenic drivers in a variety of other NK/T-cell neoplasms.
Due to significant prognostic differences and therapeutic
implications, indolent NK-cell LPDs must be distinguished
from other mature NK-cell neoplasms like aggressive NK-
cell leukemia and extranodal NK/T-cell lymphoma, nasal-
type. Marked cellular atypia, significant mitotic activity, cel-
lular necrosis, angiocentricity, or angiodestructive pattern of
growth and positive EBER ISH are features of aggressive NK-
cell disorders and clues against NKCE [1–16]. Distinction
from the exceptional cases of EBV-negative NK-cell lympho-
mamay bemore challenging due to EBV-negativity, but those
cases as the one reported byKoo et al. in the small bowel show
clearly malignant features [17]. Because of clear cells and
possible epitheliotropism, NKCEmay first elicit consideration
of a marginal zone B cell lymphoma or monomorphic
epitheliotropic intestinal T-cell lymphoma (MEITL). Even af-
ter immunophenotyping, the distinction with MEITL may re-
main difficult, given expression of antigens common to T and
NK cell lineages and strong CD56 positivity in both condi-
tions [14]. However, MEITL typically presents as a tumor
mass, harbors clonal TR gene rearrangements, and recurrent
SETD2 alterations, not found in NKCE [18].
In conclusion, we describe herein a case of nodal EBV-
negative NK-cell proliferation, akin to NKCE. This observation
further expands the spectrum of NKCE outside the GI tract.
Awareness of pathologic features of these underrecognized
LPDs is advisable, in order to avoid overdiagnosis and inappro-
priate treatment.
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